References
- Bracco P, Debernardi C, Coscia D et al. Efficacy of rofecoxib and nimesulide in controlling post-extraction pain in oral surgery: a randomised comparative study. Curr Med Res Opin 2004;20:107–12
- Solomon DH, Schneeweiss S, Glynn RJ et al. The relationship between selective COX-2 inhibitors and acute myocardial infarction. Abstract – 67th Annual Meeting of American College of Rheumatology (October 2003)
- Schmutz JL, Barbaud A, Trechot P. Rofecoxib-induced aquagenic edema with puckering of the palms of the hands: the first case. Ann Dermatol Venereol 2003;130: 813
- Coulter DM, Clark DWJ, Savage RL. Celecoxib, rofecoxib and acute temporary visual impairment. BMJ, 2003;327:1214–5
- Heeley EL, Layton D, Shakir SAW. Signal generation in prescription event monitoring: investigation of a possible signal of colitis during rofecoxib treatment. Pharmacoepidemiol Drug Safety 2002;11(Suppl 2):S242
- Zenut M, Lamaison D, Fialip J, Eschalier A. Selective COX-2 inhibitors: safety profile and evaluation in France. Pharmacoepidemiol Drug Safety 2002;11(Suppl 2):S261
- Brater DC. Renal effects of cyclooxygenase-2-selective inhibitors. J Pain Symp Manage 2002;23:S15–S20
- EMEA’s July session monthly report, EMEA/CPMP/3754/03, 1 Aug 2003. Available from http://www.emea.eu.int
- WHO Pharmaceuticals Newsletter No. 4, 2003. Available from http://www.who.int/medicines/information/infperiodicals.shtml
- Traversa G, Bianchi C, Da Cas R et al. Cohort study of hepatotoxicity associated with nimesulide and other non steroidal anti-inflammatory drugs. BMJ 2003;327:18–22
- EMEA’s November session monthly report, EMEA/CPMP/5732/03, 20 November 2003. Available from http://www.emea.eu.int
Reference
- Bracco P, Debernardi C, Coscia D et al. Efficacy of rofecoxib and nimesulide in controlling post-extraction pain in oral surgery: a randomised comparative study. Curr Med Res Opin 2004;20:107–12